Global CAR-T Cell Therapy Market Report 2023: Remarkable
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends, 2023" report has been...
Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends, 2023" report has been...
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "CAR T-Cell therapy Market By Drug type, By Indication, By End user: Global Opportunity Analysis and...
Drugmakers including Pfizer, GSK, BMS, AstraZeneca, and Sanofi plan to raise prices on more than 350 unique drugs in early January, according to data analyzed by a healthcare research firm.
Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.
The investigational, bispecific T-cell engager homes in on GPRC5D, a novel target unique to malignant plasma cells. It is awaiting approval from the Food and Drug Administration.